SCHEMBL22372823

SCHEMBL22372823

CC(C)(OC(=O)CCc1ccc(O)cc1)C1CCNCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITGB3 P05106 2/20 0.41
▸ ITGA2B P08514 2/20 0.41
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ AKR1C3 P42330 1/20 0.35
▸ CYP19A1 P11511 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ HDAC2 Q92769 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ SLC16A3 O15427 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ TTR P02766 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22373228 0.90 ITGB3 (0.41) ITGB3ITGA2BMEN1KMT2AAKR1C3
SCHEMBL26477939 0.89 ITGB3 (0.40) ITGB3ITGA2BMEN1KMT2AALDH1A1
SCHEMBL22373222 0.89 ITGB3 (0.40) ITGB3ITGA2BALDH1A1TDP1CYP4F2
SCHEMBL22372985 0.87 CYP19A1 (0.38) ITGB3ITGA2BCYP19A1ALDH1A1ESR1
SCHEMBL26412685 0.84 KCNJ1 (0.43) ITGB3ITGA2BALDH1A1LMNAGAA
SCHEMBL26412939 0.84 ESR2 (0.50) MEN1KMT2AALDH1A1LMNAESR1
SCHEMBL22372959 0.83 ALOX5 (0.51) ALDH1A1LMNACYP1A2CYP3A4GAA
SCHEMBL22372884 0.82 ITGB3 (0.40) ITGB3ITGA2BMEN1KMT2AKDM4E
SCHEMBL22373091 0.82 MEN1 (0.47) MEN1KMT2A
SCHEMBL26478075 0.81 ITGB3 (0.39) ITGB3ITGA2BMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11644753-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-05-09 — — US disclosed
US-20230131303-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-04-27 — — US disclosed
US-20230131303-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-04-27 — — US disclosed
US-20200272049-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-08-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11644753-B2 Resist composition and patterning process HNRNPU, NSUN2, HNRNPR ITGB3 1448/4885ITGA2B 2716/4885MEN1 3578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback